- Filed
- Feb 4, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · Feb 2, 2026 | 462.05M sh |
| Shares Diluted | Q2 2026 · Dec 31, 2025 | 463.8M sh |
| Shares Diluted | Q2 2026 · Dec 31, 2025 | 463M sh |
| Shares Diluted restated | Q2 2026 · Dec 31, 2024 | 289.1M sh |
| Shares Diluted restated | Q2 2026 · Dec 31, 2024 | 288.9M sh |
| Dividends Paid | Q2 2026 · Dec 31, 2025 | $594M |
| Dividends Paid | Q2 2026 · Dec 31, 2024 | $366M |
| Operating Cash Flow | Q2 2026 · Dec 31, 2025 | $370M |
| Operating Cash Flow | Q2 2026 · Dec 31, 2024 | $159M |
| Short Term Debt | Q2 2026 · Dec 31, 2025 | $83M |
| Short Term Debt | Q2 2026 · Jun 30, 2025 | $116M |
| Cash And Equivalents | Q2 2026 · Dec 31, 2025 | $1.06B |
| Cash And Equivalents | Q2 2026 · Jun 30, 2025 | $827M |
| Stockholders Equity | Q2 2026 · Dec 31, 2025 | $11.64B |
| Stockholders Equity | Q2 2026 · Jun 30, 2025 | $11.73B |
| Current Liabilities | Q2 2026 · Dec 31, 2025 | $6.58B |
| Current Liabilities | Q2 2026 · Jun 30, 2025 | $6.99B |
| Total Liabilities | Q2 2026 · Dec 31, 2025 | $25.4B |
| Total Liabilities | Q2 2026 · Jun 30, 2025 | $25.33B |
| Current Assets | Q2 2026 · Dec 31, 2025 | $8.56B |
| Current Assets | Q2 2026 · Jun 30, 2025 | $8.43B |
| Total Assets | Q2 2026 · Dec 31, 2025 | $37.05B |
| Total Assets | Q2 2026 · Jun 30, 2025 | $37.07B |
| Eps Diluted | Q2 2026 · Dec 31, 2025 | $0.38 |
| Eps Diluted | Q2 2026 · Dec 31, 2025 | $0.95 |
| Eps Diluted restated | Q2 2026 · Dec 31, 2024 | $0.56 |
| Eps Diluted restated | Q2 2026 · Dec 31, 2024 | $1.22 |
| Eps Basic | Q2 2026 · Dec 31, 2025 | $0.38 |
| Eps Basic | Q2 2026 · Dec 31, 2025 | $0.95 |
| Eps Basic restated | Q2 2026 · Dec 31, 2024 | $0.57 |
| Eps Basic restated | Q2 2026 · Dec 31, 2024 | $1.22 |
| Sga Expense | Q2 2026 · Dec 31, 2025 | $440M |
| Sga Expense | Q2 2026 · Dec 31, 2025 | $875M |
| Sga Expense restated | Q2 2026 · Dec 31, 2024 | $255M |
| Sga Expense restated | Q2 2026 · Dec 31, 2024 | $531M |
| Rd Expense | Q2 2026 · Dec 31, 2025 | $38M |
| Rd Expense | Q2 2026 · Dec 31, 2025 | $84M |
| Rd Expense | Q2 2026 · Dec 31, 2024 | $27M |
| Rd Expense | Q2 2026 · Dec 31, 2024 | $55M |
| Net Income | Q2 2026 · Dec 31, 2025 | $177M |
| Net Income | Q2 2026 · Dec 31, 2025 | $439M |
| Net Income | Q2 2026 · Dec 31, 2024 | $163M |
| Net Income | Q2 2026 · Dec 31, 2024 | $354M |
| Operating Income | Q2 2026 · Dec 31, 2025 | $331M |
| Operating Income | Q2 2026 · Dec 31, 2025 | $792M |
| Operating Income | Q2 2026 · Dec 31, 2024 | $297M |
| Operating Income | Q2 2026 · Dec 31, 2024 | $609M |
| Gross Profit | Q2 2026 · Dec 31, 2025 | $1.04B |
| Gross Profit | Q2 2026 · Dec 31, 2025 | $2.16B |
| Gross Profit | Q2 2026 · Dec 31, 2024 | $626M |
| Gross Profit | Q2 2026 · Dec 31, 2024 | $1.29B |
| Cost Of Revenue | Q2 2026 · Dec 31, 2025 | $4.41B |
| Cost Of Revenue | Q2 2026 · Dec 31, 2025 | $9.03B |
| Cost Of Revenue | Q2 2026 · Dec 31, 2024 | $2.62B |
| Cost Of Revenue | Q2 2026 · Dec 31, 2024 | $5.31B |
| Revenue | Q2 2026 · Dec 31, 2025 | $5.45B |
| Revenue | Q2 2026 · Dec 31, 2025 | $11.19B |
| Revenue | Q2 2026 · Dec 31, 2024 | $3.24B |
| Revenue | Q2 2026 · Dec 31, 2024 | $6.59B |